Research article
Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis
- Equal contributors
1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai, 200433, People's Republic of China
2 Department of Orthopaedics, the Affiliated Hospital of Nanjing Medical University, Changzhou second People's Hospital, 29 Xinglong Alley, Changzhou, 213003, People's Republic of China
3 Department of Rheumatology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, 85 Wujin Road, Shanghai, 200080, People's Republic of China
4 Department of Rheumatology and Immunology, The Third Affiliated Hospital, Suzhou University, Changzhou first People's Hospital, 185 Juqian Street, Changzhou, 213003, People's Republic of China
5 Department of Rheumatology, the Second Hospital, Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, People's Republic of China
6 Department of Gastroenterology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, 85 Wujin Road, Shanghai, 200080, People's Republic of China
7 Department of Respiratory Medicine, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, 85 Wujin Road, Shanghai, 200080, People's Republic of China
8 Clinical laboratory, the Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, 29 Xinglong Alley, Changzhou, 213003, People's Republic of China
Arthritis Research & Therapy 2011, 13:R17 doi:10.1186/ar3241
Published: 8 February 2011Additional files
Additional file 1:
Supplementary data. Figure S1. Distribution of serum follistatin-like protein 1 (FSTL1) levels in the different groups including the healthy controls and the patients with systemic autoimmune diseases. Table S1. Descriptive statistics of serum follistatin-like protein 1 (FSTL1) levels in the different groups including the healthy controls and the patients with systemic autoimmune diseases.
Format: DOC Size: 744KB Download file
This file can be viewed with: Microsoft Word Viewer


